Aspirin impairs reverse myocardial remodeling in patients with heart failure treated with beta-blockers (Q28191849)

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901641-2

7 January 2021

Contribution of prostaglandins to the antihypertensive action of captopril in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901641-2

7 January 2021

Kinins, nitric oxide, and the hypotensive effect of captopril and ramiprilat in hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901641-2

7 January 2021

Combining salicylate and enalapril in patients with coronary artery disease and heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901641-2

7 January 2021

Acute hemodynamic interaction of aspirin and ticlopidine with enalapril: results of a double-blind, randomized comparative trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901641-2

7 January 2021

Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901641-2

7 January 2021

Interaction between enalapril and aspirin on mortality after acute myocardial infarction: subgroup analysis of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901641-2

7 January 2021

Use of converting enzyme inhibitors in patients with asymptomatic left ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901641-2

7 January 2021

Aspirin and mortality in patients treated with angiotensin-converting enzyme inhibitors: a cohort study of 11,575 patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901641-2

7 January 2021

Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin: systematic overview of individual data from 96,712 randomized patients. Angiotensin-conve

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901641-2

7 January 2021

Effects of Aspirin on Angiotensin-Converting Enzyme Inhibition and Left Ventricular Dilation One Year After Acute Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901641-2

7 January 2021

Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901641-2

7 January 2021

Differential effects of antihypertensive drugs on neurohormonal activation: insights from a population-based sample

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901641-2

7 January 2021

Augmentation of the cardiac natriuretic peptides by beta-receptor antagonism: evidence from a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901641-2

7 January 2021

Prostaglandins regulate the synthesis and secretion of the atrial natriuretic peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901641-2

7 January 2021

Bradykinin B2-receptor activation augments norepinephrine exocytosis from cardiac sympathetic nerve endings. Mediation by autocrine/paracrine mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901641-2

7 January 2021

Prostaglandins in severe congestive heart failure. Relation to activation of the renin--angiotensin system and hyponatremia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901641-2

7 January 2021

Bicyclo-prostaglandin E2 metabolite in congestive heart failure and relation to vasoconstrictor neurohumoral principles

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901641-2

7 January 2021

Aspirin test for differentiation of unilateral renovascular hypertension from hyperreninemic essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901641-2

7 January 2021

Hypotensive mechanisms of beta blockers

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901641-2

7 January 2021

Why does the myocardium fail? Insights from basic science

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901641-2

7 January 2021

Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901641-2

7 January 2021

Differential Inhibition by Aspirin of Vascular and Platelet Prostaglandin Synthesis in Atherosclerotic Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901641-2

7 January 2021

Aspirin causes short-lived inhibition of bradykinin-stimulated prostacyclin production in man

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901641-2

7 January 2021

Even low-dose aspirin inhibits arachidonic acid-induced vasodilation in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901641-2

7 January 2021

Predicting response to carvedilol for the treatment of heart failure: a multivariate retrospective analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901641-2

7 January 2021